ASTRAZENECA GETS CDSCO APPROVAL TO IMPORT REVOLUTIONARY ANTI-CANCER DRUG “LYNPARZA”
AstraZeneca Pharma India has received CDSCO approval to import its anti-cancer drug Lynparza (olaparib) in 100 mg and 150 mg…
cdsco
Read More
Central Drugs Standard Control Organization Joins IMDRF, Transforming India’s Medical Device Regulation for an Even Safer and Healthier Future
Central Drugs Standard Control Organization Joins International Medical Device Regulators Forum as Affiliate Member Central Drugs Standard Control Organization (CDSCO),…
“AstraZeneca India Secures CDSCO Approval: Expanding Breakthrough Life-Saving Chemotherapy Options to Empower Cancer Treatment”
AstraZeneca India Receives CDSCO Approval for Additional Indications of Its Chemotherapy Drug Astrazeneca, a leading biopharmaceutical company, has achieved a…